Comments for LLY - Stockpickr! Your Source for Stock Ideas

Comments for LLY

Added By	Comments	Type	Date Added
heron15	negative eps	Hate	September 09, 2009
gmarczewski	endures all the heat pays almost 6%	Love	September 01, 2009
gmarczewski	endures all the heat pays almost 6%	Love	September 01, 2009
barrons3	As for the rest of Big Pharma, Ryan sees dividends staying flat because of merger loans. "While making acquisitions, Merck [MRK], Eli Lilly [LLY] and Bristol-Myers Squibb [BMY] have not reduced dividends; however, we suspect that this means that they are unlikely to increase them much in the future."	Love	August 15, 2009
barrons3	Second is Eli Lilly (LLY), the best of the highest-yielding drug stocks and one that I find could have an acceleration in earnings. The ImClone deal looks like a good one, even as initially I thought they paid too much.	Love	May 07, 2009
sarah z	From a recent Mad Money show:"I think the government is taking aim at big pharma. So anyone like Lily is going to have prices driven down. That's a big change for me, but I can't recommend them."	Love	March 05, 2009
sarah z	From a recent Mad Money show:"I think the government is taking aim at big pharma. So anyone like Lily is going to have prices driven down. That's a big change for me, but I can't recommend them."	Love	March 03, 2009
barrons3	The drug sector is well represented with industry leaders Merck, Bristol-Myers, Lilly and Pfizer. Dividends at all four look secure, although future payout increases could be muted by modest annual profit growth. The new Pfizer dividend of 64 cents annually, for a 4.5% yield, looks safe at just 30% of projected 2009 earnings. The negative investor reaction to the Pfizer payout cut may make other drug makers wary of reducing dividends.	Love	February 14, 2009
barrons3	How about how the market shrugs off the Lilly (LLY) approval of a Plavix killer -- bread-and-butter for Bristol (BMY) --and takes up BMY anyway!	Love	February 05, 2009
geb1	lots of cash	Love	January 20, 2009
Trading Nymph	2:30	Love	December 30, 2008
dfgmd2	future growth	Love	December 29, 2008
Lesley T. Morris	Dividend.	Love	December 25, 2008
barrons3	Moving to Eli Lilly (LLY), the pharmaceutical giant announced that it will pay a sweetened dividend of 49 cents a share on March 10 to stockholders of record Feb. 13; the ex-date is Feb. 11. That makes 42 consecutive years of increased disbursements. Lilly has distributed dividends every year since 1885. Traded on the New York Stock Exchange, Lilly shares are around 38. Their 52-week range is 57.52-28.62. Yield: 5.15%. Lilly hasn't brought a new drug to market in three years, and its top-selling products face generic competition beginning in 2011. But it has a plan. It will focus heavily on biotech drugs (it's already the fifth-largest U.S. biotech outfit), continue to cut costs via outsourcing, sell assets, form partnerships and restock its medicine chest (it has 59 experimental drugs in its pipeline, the most ever). The company expects to lose $1.56 to $2.06 a share this year because of expenses related to its $6.5 billion takeover of ImClone Systems. In 2009, however, it has its sights set on profits of $4 to $4.25 a share on record sales. Without ImClone costs, Lilly would be looking at $4.35 to $4.55.	Love	December 20, 2008
High Dividends	Percentage increase: 4.30% Yield: 5.3%	Love	December 20, 2008
sarah z	“Oh, doctor! Eli Lilly (LLY) blows up and it goes higher. You would think it is a steel company! Now, here's what I know about Eli Lilly (besides the fact that its bountiful dividend can be covered easily out of those earnings): It has a fabulous chart, and in an endlessly technically driven market, that means upside. Last weekend I bumped into my old friend Justin Mamis, the godfather of technicians and a teacher of our own esteemed Helene Meisler. We had the following discussion. It went like this: "Hi Justin." "Hi Jim, the pharmas have bottomed. Lilly is rock-solid and done going down." So what do I do? Like a moron, I look at the fundamentals, I know they are about to talk, I sense the numbers are too high -- that's the case for almost all big pharma -- I know that stocks get hammered when they cut numbers, and I know to stay away. Oops! Now, I know people are willing to believe that Texas Instruments (TXN) and National Semi (NSM) and Broadcom (BRCM) have bottomed even though there is nothing good about to happen to those. I don't get that. But when I scan what Lilly's saying, I do get the sense that, at last, the worst is over (although I don't like Tom Daschle as my drug czar, as he might be willing to use the government's buying power to hold down the cost of Lilly's drugs to Medicare). My point: I like a bottom where there is a base and where there is a reason -- that's what we are getting with LLY. I don't like a "bottom" where numbers aren't low enough and the prospects are for more bleak numbers. And I wish I had just listened to Justin without doing homework!”	Love	December 11, 2008
stockerblog	5.62%	Love	October 26, 2008
stockerblog	5.5%	Love	October 20, 2008
shelleyaw123	they make my son's insulin	Love	October 17, 2008
stockerblog	PE of 9, a PEG of 1.43, and it pays a yield of 5%.	Love	October 14, 2008
stockerblog	8/13/2008	Love	July 26, 2008
barrons2	When asked about upcoming numbers, he was optimistic that "both Eli Lilly(LLY) and Bristol-Myers Squibb(BMY) likely have the best numbers."	Love	July 23, 2008
barrons2	As well as more details from Eli Lilly (LLY) on Alimta, its drug for lung cancer.	Love	May 29, 2008
barrons2	Ryan is negative on Eli Lilly (LLY), which she sees as having a mature product portfolio while being behind the curve in cost cutting.	Love	April 26, 2008
barrons2	Moderate Outperform - Price 49.59 on April 23 by First Global Due to strong top- and bottom-line growth expected for calendar '08...we believe LLY deserves to trade at higher multiples. Recent overhang on LLY [due to platelet-inhibitor] Prasugrel...appears overdone. Final approval of Prasugrel will be the key trigger for the stock. Estimated price/earnings for '08: 12.5 times. Market cap: $54.3 billion.	Love	April 26, 2008
barrons2	But the group is bizarrely despised. Lilly (LLY) getting killed again by yesterday's lackluster quarter	Love	April 24, 2008
stockerblog	Cymbalta, Zyprexa	Love	April 21, 2008
kcrad68372	Good for option trade	Love	April 16, 2008
barrons2	Lilly is in phase III testing of its own Alzheimer's drug, Najarian said.	Love	April 09, 2008
stockerblog	eighth best selling drug, Zyprexa, used to treat schizophrenia, and has a patent expiration of 2011.	Love	April 06, 2008